Funtleyder Les's Insider Trades & SAST Disclosures
Funtleyder Les's most recent trade in Applied Therapeutics Inc was a trade of 350,000 Common Stock done . Disclosure was reported to the exchange on March 24, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Funtleyder Les.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Applied Therapeutics Inc | Les Funtleyder | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2025 | 350,000 | 740,459 (3%) | 1% | 0 | Common Stock | |
| Applied Therapeutics Inc | Les Funtleyder | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 0.44 per share. | 04 Mar 2025 | 14,502 | 390,459 (2%) | 0% | 0.4 | 6,381 | Common Stock |
| Applied Therapeutics Inc | Les Funtleyder | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 0.61 per share. | 06 Feb 2025 | 22,950 | 404,961 (2%) | 0% | 0.6 | 14,000 | Common Stock |
| Applied Therapeutics Inc | Les Funtleyder | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2024 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Funtleyder Les | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2024 | 150,000 | 427,911 (2%) | 0% | 0 | Common Stock | |
| Reviva Pharmaceuticals Hol... | Les Funtleyder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2024 | 8,200 | 8,200 | - | - | Stock Option (right to buy) | |
| Applied Therapeutics Inc | Les Funtleyder | Director, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 5.83 per share. | 22 Aug 2024 | 13,530 | 277,911 (1%) | 0% | 5.8 | 78,880 | Common Stock |
| Applied Therapeutics Inc | Les Funtleyder | Director, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 4.32 per share. | 06 Jun 2024 | 16,980 | 291,441 (1%) | 0% | 4.3 | 73,354 | Common Stock |
| Applied Therapeutics Inc | Les Funtleyder | Director, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 5.39 per share. | 14 Mar 2024 | 28,727 | 308,421 (1%) | 0% | 5.4 | 154,839 | Common Stock |
| Applied Therapeutics Inc | Les Funtleyder | Director, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2023 | 300,000 | 337,148 (1%) | 1% | 0 | Common Stock | |
| Applied Therapeutics Inc | Les Funtleyder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 20,000 | 37,148 (0%) | 0% | 0 | Common Stock | |
| Reviva Pharmaceuticals Hol... | Les Funtleyder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Nov 2022 | 3,900 | 3,900 | - | - | Stock Option (right to buy) | |
| Applied Therapeutics Inc | Les Funtleyder | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 20,460 | 20,460 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Les Funtleyder | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 20,460 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Les Funtleyder | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 16,500 | 16,500 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Les Funtleyder | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 16,500 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Les Funtleyder | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 16,500 | 16,500 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Les Funtleyder | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 16,500 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Les Funtleyder | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 10,230 | 10,230 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Les Funtleyder | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 10,230 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Les Funtleyder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2022 | 16,500 | 16,500 | - | - | Stock Option (Right to Buy) | |
| Reviva Pharmaceuticals Hol... | Les Funtleyder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2021 | 5,300 | 5,300 | - | - | Stock Option (right to buy) | |
| Applied Therapeutics Inc | Les Funtleyder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2021 | 16,500 | 16,500 | - | - | Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Les Funtleyder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2020 | 30,000 | 40,502 | - | - | Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Les Funtleyder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.70 per share. | 01 Oct 2020 | 30,000 | 47,148 (0%) | 0% | 4.7 | 141,000 | Common Stock |
| Applied Therapeutics Inc | Les Funtleyder | Director | Sale of securities on an exchange or to another person at price $ 20.03 per share. | 01 Oct 2020 | 22,671 | 24,477 (0%) | 0% | 20.0 | 454,100 | Common Stock |
| Applied Therapeutics Inc | Les Funtleyder | Director | Sale of securities on an exchange or to another person at price $ 20.07 per share. | 01 Oct 2020 | 5,976 | 17,148 (0%) | 0% | 20.1 | 119,938 | Common Stock |
| Applied Therapeutics Inc | Les Funtleyder | Director | Sale of securities on an exchange or to another person at price $ 20.75 per share. | 01 Oct 2020 | 1,353 | 23,124 (0%) | 0% | 20.8 | 28,075 | Common Stock |
| Applied Therapeutics Inc | Les Funtleyder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Aug 2020 | 20,000 | 70,502 | - | - | Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Les Funtleyder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.70 per share. | 21 Aug 2020 | 20,000 | 37,148 (0%) | 0% | 4.7 | 94,000 | Common Stock |
| Applied Therapeutics Inc | Les Funtleyder | Director | Sale of securities on an exchange or to another person at price $ 23.42 per share. | 21 Aug 2020 | 13,539 | 23,609 (0%) | 0% | 23.4 | 317,083 | Common Stock |
| Applied Therapeutics Inc | Les Funtleyder | Director | Sale of securities on an exchange or to another person at price $ 24.18 per share. | 21 Aug 2020 | 6,461 | 17,148 (0%) | 0% | 24.2 | 156,227 | Common Stock |
| Applied Therapeutics Inc | Les Funtleyder | Director | Sale of securities on an exchange or to another person at price $ 43.32 per share. | 23 Jun 2020 | 4,629 | 32,519 (0%) | 0% | 43.3 | 200,528 | Common Stock |
| Applied Therapeutics Inc | Les Funtleyder | Director | Sale of securities on an exchange or to another person at price $ 40.41 per share. | 23 Jun 2020 | 3,811 | 18,365 (0%) | 0% | 40.4 | 154,003 | Common Stock |
| Applied Therapeutics Inc | Les Funtleyder | Director | Sale of securities on an exchange or to another person at price $ 39.20 per share. | 23 Jun 2020 | 3,572 | 22,176 (0%) | 0% | 39.2 | 140,022 | Common Stock |
| Applied Therapeutics Inc | Les Funtleyder | Director | Sale of securities on an exchange or to another person at price $ 44.54 per share. | 23 Jun 2020 | 3,462 | 29,057 (0%) | 0% | 44.5 | 154,197 | Common Stock |
| Applied Therapeutics Inc | Les Funtleyder | Director | Sale of securities on an exchange or to another person at price $ 45.35 per share. | 23 Jun 2020 | 1,809 | 27,248 (0%) | 0% | 45.3 | 82,038 | Common Stock |
| Applied Therapeutics Inc | Les Funtleyder | Director | Sale of securities on an exchange or to another person at price $ 47.40 per share. | 23 Jun 2020 | 1,340 | 25,748 (0%) | 0% | 47.4 | 63,516 | Common Stock |
| Applied Therapeutics Inc | Les Funtleyder | Director | Sale of securities on an exchange or to another person at price $ 37.52 per share. | 23 Jun 2020 | 517 | 17,248 (0%) | 0% | 37.5 | 19,398 | Common Stock |
| Applied Therapeutics Inc | Les Funtleyder | Director | Sale of securities on an exchange or to another person at price $ 40.92 per share. | 23 Jun 2020 | 400 | 17,965 (0%) | 0% | 40.9 | 16,368 | Common Stock |
| Applied Therapeutics Inc | Les Funtleyder | Director | Sale of securities on an exchange or to another person at price $ 36.12 per share. | 23 Jun 2020 | 200 | 17,765 (0%) | 0% | 36.1 | 7,224 | Common Stock |
| Applied Therapeutics Inc | Les Funtleyder | Director | Sale of securities on an exchange or to another person at price $ 46.45 per share. | 23 Jun 2020 | 160 | 27,088 (0%) | 0% | 46.5 | 7,432 | Common Stock |
| Applied Therapeutics Inc | Les Funtleyder | Director | Sale of securities on an exchange or to another person at price $ 38.28 per share. | 23 Jun 2020 | 100 | 17,148 (0%) | 0% | 38.3 | 3,828 | Common Stock |
| Applied Therapeutics Inc | Les Funtleyder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jun 2020 | 20,000 | 90,502 | - | - | Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Les Funtleyder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.70 per share. | 18 Jun 2020 | 20,000 | 37,148 (0%) | 0% | 4.7 | 94,000 | Common Stock |
| Applied Therapeutics Inc | Les Funtleyder | Director | Sale of securities on an exchange or to another person at price $ 45.32 per share. | 18 Jun 2020 | 7,487 | 17,159 (0%) | 0% | 45.3 | 339,311 | Common Stock |
| Applied Therapeutics Inc | Les Funtleyder | Director | Sale of securities on an exchange or to another person at price $ 45.91 per share. | 18 Jun 2020 | 11 | 17,148 (0%) | 0% | 45.9 | 505 | Common Stock |
| Applied Therapeutics Inc | Les Funtleyder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2020 | 17,000 | 110,502 | - | - | Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Les Funtleyder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.70 per share. | 15 Jun 2020 | 17,000 | 34,148 (0%) | 0% | 4.7 | 79,900 | Common Stock |
| Applied Therapeutics Inc | Les Funtleyder | Director | Sale of securities on an exchange or to another person at price $ 44.37 per share. | 15 Jun 2020 | 5,302 | 28,846 (0%) | 0% | 44.4 | 235,250 | Common Stock |
| Applied Therapeutics Inc | Les Funtleyder | Director | Sale of securities on an exchange or to another person at price $ 44.15 per share. | 15 Jun 2020 | 4,100 | 24,646 (0%) | 0% | 44.2 | 181,015 | Common Stock |
| Applied Therapeutics Inc | Les Funtleyder | Director | Sale of securities on an exchange or to another person at price $ 45.18 per share. | 15 Jun 2020 | 100 | 28,746 (0%) | 0% | 45.2 | 4,518 | Common Stock |
| Applied Therapeutics Inc | Les Funtleyder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2020 | 17,000 | 127,502 | - | - | Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Les Funtleyder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.70 per share. | 08 Jun 2020 | 17,000 | 34,148 (0%) | 0% | 4.7 | 79,900 | Common Stock |
| Applied Therapeutics Inc | Les Funtleyder | Director | Sale of securities on an exchange or to another person at price $ 44.77 per share. | 08 Jun 2020 | 8,315 | 25,833 (0%) | 0% | 44.8 | 372,263 | Common Stock |
| Applied Therapeutics Inc | Les Funtleyder | Director | Sale of securities on an exchange or to another person at price $ 41.80 per share. | 08 Jun 2020 | 2,622 | 19,711 (0%) | 0% | 41.8 | 109,600 | Common Stock |
| Applied Therapeutics Inc | Les Funtleyder | Director | Sale of securities on an exchange or to another person at price $ 42.83 per share. | 08 Jun 2020 | 2,563 | 17,148 (0%) | 0% | 42.8 | 109,773 | Common Stock |
| Applied Therapeutics Inc | Les Funtleyder | Director | Sale of securities on an exchange or to another person at price $ 42.82 per share. | 08 Jun 2020 | 2,000 | 23,833 (0%) | 0% | 42.8 | 85,640 | Common Stock |
| Applied Therapeutics Inc | Les Funtleyder | Director | Sale of securities on an exchange or to another person at price $ 44.87 per share. | 08 Jun 2020 | 1,500 | 22,333 (0%) | 0% | 44.9 | 67,305 | Common Stock |
| Applied Therapeutics Inc | Les Funtleyder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.70 per share. | 02 Jun 2020 | 15,000 | 32,148 (0%) | 0% | 4.7 | 70,500 | Common Stock |
| Applied Therapeutics Inc | Les Funtleyder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2020 | 15,000 | 144,502 | - | - | Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Les Funtleyder | Director | Sale of securities on an exchange or to another person at price $ 45.21 per share. | 02 Jun 2020 | 12,486 | 19,662 (0%) | 0% | 45.2 | 564,492 | Common Stock |
| Applied Therapeutics Inc | Les Funtleyder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2020 | 10,230 | 10,230 | - | - | Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Les Funtleyder | Director | Sale of securities on an exchange or to another person at price $ 44.17 per share. | 02 Jun 2020 | 1,482 | 17,148 (0%) | 0% | 44.2 | 65,460 | Common Stock |
| Applied Therapeutics Inc | Les Funtleyder | Director | Sale of securities on an exchange or to another person at price $ 44.03 per share. | 02 Jun 2020 | 1,032 | 18,630 (0%) | 0% | 44.0 | 45,439 | Common Stock |
| Applied Therapeutics Inc | Les Funtleyder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.04 per share. | 28 May 2020 | 18,453 | 35,601 (0%) | 0% | 0.0 | 738 | Common Stock |
| Applied Therapeutics Inc | Les Funtleyder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2020 | 18,453 | 0 | - | - | Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Les Funtleyder | Director | Sale of securities on an exchange or to another person at price $ 45.08 per share. | 28 May 2020 | 8,495 | 17,148 (0%) | 0% | 45.1 | 382,955 | Common Stock |
| Applied Therapeutics Inc | Les Funtleyder | Director | Sale of securities on an exchange or to another person at price $ 44.27 per share. | 28 May 2020 | 7,120 | 25,643 (0%) | 0% | 44.3 | 315,202 | Common Stock |
| Applied Therapeutics Inc | Les Funtleyder | Director | Sale of securities on an exchange or to another person at price $ 48.27 per share. | 28 May 2020 | 2,838 | 32,763 (0%) | 0% | 48.3 | 136,990 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges